Targeting VEGF pathway to normalize the vasculature: an emerging insight in cancer therapy

Abstract

Vascular normalization is a new concept of targeting angiogenesis to restore vessel structure and function and to increase blood perfiision and delivery of drugs. It has been confirmed that vascular normalization can decrease relapse and benefit other cancer therapy, including chemotherapy, radiotherapy, and inunune cell therapy. The key point of this therapy is to inhibit pro-angiogenic factors and make it be balanced with anti-angiogenic factors, resulting in a mature and normal vessel characteristic. Vascular endothelial growth factor (VEGF) is a key player in the process of tumor angiogenesis, and inhibiting VEGF is a primary approach to tumor vessel normalization. Herein, we review newly uncovered mechanisms governing angiogenesis and vascular normalization of cancer and place emphasis on targeting VEGF pathway to normalize the vascul Mitre. Also, important methods to depress VEGF pathway and make tumor vascular are discussed.